Looks like 
TDOC may have found some support around the $170 area. I opened a small starter position this morning to try and play that bounce. This is a high risk trade as it's below ALL moving averages. Do your own due diligence. I like the name and what they do. They beat on earnings and guided slightly higher but got beat down, guidance not high enough? Ideas, not investing / trading advice.
from earningswhispers.com:
Teladoc Health Beats
Teladoc Health (TDOC) reported 1st Quarter March 2021 earnings of $0.13 per share on revenue of $453.7 million. The consensus estimate was a loss of $0.57 per share on revenue of $451.9 million. The Earnings Whisper number was for a loss of $0.66 per share. Revenue grew 150.9% on a year-over-year basis.
The company said it expects second quarter revenue of $495.0 million to $505.0 million and 2021 revenue of $1.97 billion to $2.02 billion. the company's previous guidance was 2021 revenue of $1.95 billion to $2.00 billion. The current consensus revenue estimate is $486.39 million for the quarter ending June 30, 2021 and revenue of $1.99 billion for the year ending December 31, 2021.
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey.
TDOC may have found some support around the $170 area. I opened a small starter position this morning to try and play that bounce. This is a high risk trade as it's below ALL moving averages. Do your own due diligence. I like the name and what they do. They beat on earnings and guided slightly higher but got beat down, guidance not high enough? Ideas, not investing / trading advice.from earningswhispers.com:
Teladoc Health Beats
Teladoc Health (TDOC) reported 1st Quarter March 2021 earnings of $0.13 per share on revenue of $453.7 million. The consensus estimate was a loss of $0.57 per share on revenue of $451.9 million. The Earnings Whisper number was for a loss of $0.66 per share. Revenue grew 150.9% on a year-over-year basis.
The company said it expects second quarter revenue of $495.0 million to $505.0 million and 2021 revenue of $1.97 billion to $2.02 billion. the company's previous guidance was 2021 revenue of $1.95 billion to $2.00 billion. The current consensus revenue estimate is $486.39 million for the quarter ending June 30, 2021 and revenue of $1.99 billion for the year ending December 31, 2021.
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey.
Ideas I publish are my own. They are not meant to be investment / trading advice. You are encouraged to do your own due diligence.
I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Ideas I publish are my own. They are not meant to be investment / trading advice. You are encouraged to do your own due diligence.
I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.